Literature DB >> 7595211

T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.

S Morkowski1, A W Goldrath, S Eastman, L Ramachandra, D C Freed, P Whiteley.   

Abstract

Peptides from the lumenal portion of invariant chain (Ii) spanning residues 80-106 (class II-associated Ii peptide [CLIP]) are found in association with several mouse and human major histocompatibility complex (MHC) class II allelic variants in wild-type and presentation-deficient mutant cells. The ready detection of these complexes suggests that such an intermediate is essential to the MHC class II processing pathway. In this study, we demonstrate that T cells recognize CLIP/MHC class II complexes on the surface of normal and mutant cells in a manner indistinguishable from that of nominal antigenic peptides. Surprisingly, T cell hybrids specific for human CLIP bound to murine MHC class II molecule I-Ab and a new monoclonal antibody 30-2 with the same specificity, recognize two independent epitopes expressed on this peptide/class II complex. T cell recognition is dependent on a Gln residue (position 100) in CLIP, whereas the 30-2 antibody recognizes a Lys residue-at position 90. These two residues flank the 91-99 sequence that is conserved among human, mouse, and rat Ii, potentially representing an MHC class II-binding site. Our results suggest that the COOH-terminal portion of CLIP that includes TCR contact residue Gln 100 binds in the groove of I-Ab molecule. Moreover, both T cells and the antibody recognize I-Ab complexed with larger Ii processing intermediates such as the approximately 12-kD small leupeptin-induced protein (SLIP) fragments. Thus, SLIP fragments contain a CLIP region bound to MHC class II molecule in a conformation identical to that of a free CLIP peptide. Finally, our data suggest that SLIP/MHC class II complexes are precursors of CLIP/MHC class II complexes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7595211      PMCID: PMC2192223          DOI: 10.1084/jem.182.5.1403

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  35 in total

1.  The antigen-processing mutant T2 suggests a role for MHC-linked genes in class II antigen presentation.

Authors:  J M Riberdy; P Cresswell
Journal:  J Immunol       Date:  1992-04-15       Impact factor: 5.422

2.  HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides.

Authors:  J M Riberdy; J R Newcomb; M J Surman; J A Barbosa; P Cresswell
Journal:  Nature       Date:  1992-12-03       Impact factor: 49.962

3.  Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad.

Authors:  D F Hunt; H Michel; T A Dickinson; J Shabanowitz; A L Cox; K Sakaguchi; E Appella; H M Grey; A Sette
Journal:  Science       Date:  1992-06-26       Impact factor: 47.728

4.  Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated alpha beta dimers.

Authors:  J R Newcomb; P Cresswell
Journal:  J Immunol       Date:  1993-01-15       Impact factor: 5.422

5.  In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides.

Authors:  R R Avva; P Cresswell
Journal:  Immunity       Date:  1994-12       Impact factor: 31.745

6.  Mice lacking the MHC class II-associated invariant chain.

Authors:  S Viville; J Neefjes; V Lotteau; A Dierich; M Lemeur; H Ploegh; C Benoist; D Mathis
Journal:  Cell       Date:  1993-02-26       Impact factor: 41.582

7.  The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy.

Authors:  P Romagnoli; R N Germain
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

8.  Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules.

Authors:  G Malcherek; V Gnau; G Jung; H G Rammensee; A Melms
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

9.  Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression.

Authors:  E K Bikoff; L Y Huang; V Episkopou; J van Meerwijk; R N Germain; E J Robertson
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

10.  Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistance alpha beta heterodimers in endosomes.

Authors:  J J Neefjes; H L Ploegh
Journal:  EMBO J       Date:  1992-02       Impact factor: 11.598

View more
  11 in total

1.  Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein.

Authors:  G Zhong; C Reis e Sousa; R N Germain
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

2.  Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region.

Authors:  P Stumptner; P Benaroch
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

3.  Reduction of myeloid-derived suppressor cells and lymphoma growth by a natural triterpenoid.

Authors:  Faisal F Y Radwan; Azim Hossain; Jason M God; Nathan Leaphart; Michelle Elvington; Mitzi Nagarkatti; Stephen Tomlinson; Azizul Haque
Journal:  J Cell Biochem       Date:  2015-01       Impact factor: 4.429

4.  GILT expression in B cells diminishes cathepsin S steady-state protein expression and activity.

Authors:  Hannah Phipps-Yonas; Vikki Semik; Karen Taraszka Hastings
Journal:  Eur J Immunol       Date:  2012-11-26       Impact factor: 5.532

5.  Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.

Authors:  M Krogsgaard; K W Wucherpfennig; B Cannella; B E Hansen; A Svejgaard; J Pyrdol; H Ditzel; C Raine; J Engberg; L Fugger; B Canella
Journal:  J Exp Med       Date:  2000-04-17       Impact factor: 14.307

6.  Cathepsin L regulates CD4+ T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands.

Authors:  Karen Honey; Terry Nakagawa; Christoph Peters; Alexander Rudensky
Journal:  J Exp Med       Date:  2002-05-20       Impact factor: 14.307

7.  A Missing Switch in Peptide Exchange for MHC Class II Molecules.

Authors:  Christian Freund; Thomas Höfer
Journal:  Front Immunol       Date:  2019-10-23       Impact factor: 7.561

8.  Bystander CD4 T cells do not mediate demyelination in mice infected with a neurotropic coronavirus.

Authors:  Jodie S Haring; Stanley Perlman
Journal:  J Neuroimmunol       Date:  2003-04       Impact factor: 3.478

9.  Transcription factor Foxp3 and its protein partners form a complex regulatory network.

Authors:  Dipayan Rudra; Paul deRoos; Ashutosh Chaudhry; Rachel E Niec; Aaron Arvey; Robert M Samstein; Christina Leslie; Scott A Shaffer; David R Goodlett; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2012-08-26       Impact factor: 25.606

Review 10.  A role for NADPH oxidase in antigen presentation.

Authors:  Gail J Gardiner; Sarah N Deffit; Shawna McLetchie; Liliana Pérez; Crystal C Walline; Janice S Blum
Journal:  Front Immunol       Date:  2013-09-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.